Neogen (NASDAQ:NEOG) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 46.67 percent decrease over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $128.31 million which beat the analyst consensus estimate of $121.20 million by 5.86 percent. This is a 17.36 percent increase over sales of $109.33 million the same period last year.
Neogen Q1 EPS $0.16, Inline, Sales $128.31M Beat $121.20M Estimate
Neogen (NASDAQ:NEOG) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 46.67 percent decrease over earnings of $0.30 per share from the same period last year. The company
Related Posts
A Preview Of Hershey’s Earnings
February 2, 11:13 AM
Hershey (NYSE:HSY) is set to give its latest quarterly earnings report on Thursday, 2022-02-03. Here's what investors need to know before the announcement.
Analysts estimate that Hershey will likely report an Earnings Per Share (EPS) of $1.61.
Advent, BASF Ink MoU To Secure Supply Chain For Large Scale Projects
December 13, 4:30 PM
Advent Technologies Holdings Inc (NASDAQ:ADN) and BASF SE (OTC:BASFY) unit BASF New Business GmbH have signed a Memorandum of Understanding (MoU) to develop…
HC Wainwright & Co. Maintains Buy on Addex Therapeutics, Lowers Price Target to $21
February 11, 7:29 AM
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Addex Therapeutics (NASDAQ:ADXN) with a Buy and lowers the price target from $28 to $21.